Yahoo Web Search

Search results

  1. Apr 18, 2023 · A preliminary randomized placebo-controlled clinical trial (SLCTR/2014/023) testing efficacy of rupatadine for acute dengue patients revealed improved platelet counts, reduction in liver transaminases suggesting reduced tissue inflammation, and reduction in volume of plural effusions on certain days of the study protocol in their post hoc ...

  2. Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial - The Lancet Global Health. Articles | Volume 12, ISSUE 2, e257-e270, February 2024. Download Full Issue.

  3. People also ask

  4. Nov 6, 2019 · Methods. We present primary efficacy data from part 1 of an ongoing phase 3 randomized trial of a tetravalent dengue vaccine candidate (TAK-003) in regions of Asia and Latin America in which...

    • Shibadas Biswal, Humberto Reynales, Xavier Saez-Llorens, Pio Lopez, Charissa Borja-Tabora, Pope Kosa...
    • 2019
  5. Sep 24, 2015 · A recombinant, live, attenuated, tetravalent dengue vaccine (CYD-TDV) has been assessed in two phase 3 randomized efficacy trials involving more than 31,000 children between the ages of 2 and...

    • Hadinegoro, Arredondo-García Jl, Capeding Mr, Deseda C, Chotpitayasunondh T, Dietze R, Muhammad Isma...
    • 2015
  6. Apr 12, 2012 · The establishment of a therapeutic pipeline and the design of randomized, controlled trials of drugs targeting the virus or the immune response are recent developments.

  1. People also search for